Merck 2017 forecast reassuring; full-speed ahead with Keytruda
Go back to Merck 2017 forecast reassuring; full-speed ahead with Keytruda| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 62.09 +0.58 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.51 | 52 Week High | $77.12 | |||
| Open | $61.94 | 52 Week Low | $49.03 | |||
| Day High | $62.82 | P/E | 40.32 | |||
| Day Low | $61.60 | EPS | $1.54 | |||
| Volume | 12,071,309 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 131.07 +0.59 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.48 | 52 Week High | $65.46 | |||
| Open | $131.44 | 52 Week Low | $47.97 | |||
| Day High | $131.71 | P/E | 89.16 | |||
| Day Low | $130.24 | EPS | $1.47 | |||
| Volume | 6,154,306 | |||||
